[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354955-105":59,"doc-detail-354955-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-interaction-of-circesr1-and-hnrnpab-regulates-cell-cycle-transition-of-breast-cancer-cell","The Interaction of CircESR1 and HNRNPAB Regulates Cell Cycle Transition of Breast Cancer Cell","","The mechanisms by which circRNAs regulate estrogen receptor (ER)-positive breast progression and therapeutic resistance remain poorly defined. CircESR1 is identified as a circRNA with high specificity in ER+ breast cancer and is transcriptionally activated through ER/SP1 signaling. CircESR1 binds HNRNPAB, promoting circESR1 back-splicing via Alu elements and stabilizing HNRNPAB to establish a positive feedback loop. HNRNPAB stabilizes CDK1 and CDK6 mRNAs to drive cell cycle progression. High circESR1/HNRNPAB levels predict worse outcomes, and combining circESR1 ASO with CDK4/6 inhibitors overcomes antiestrogen resistance in xenograft models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-interaction-of-circesr1-and-hnrnpab-regulates-cell-cycle-transition-of-breast-cancer-cell/354955/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-interaction-of-circesr1-and-hnrnpab-regulates-cell-cycle-transition-of-breast-cancer-cell/354955.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What circRNA is identified as a key regulator in ER+ breast cancer signaling?","Question",{"text":112,"@type":113},"circESR1 is identified as a novel circRNA with high expression specificity in ER+ breast cancer, acting within an ER/SP1–driven regulatory context.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does circESR1 interact with HNRNPAB and what is the consequence?",{"text":117,"@type":113},"circESR1 interacts with HNRNPAB, which is transcriptionally activated by ER/SP1 signaling. HNRNPAB promotes circESR1 back-splicing and expression, and circESR1 transcripts enhance HNRNPAB stability and expression, forming a positive feedback loop.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecules are stabilized by HNRNPAB to promote cell cycle progression and therapy response?",{"text":121,"@type":113},"HNRNPAB interacts with and stabilizes CDK1 and CDK6 mRNA. This supports cell cycle progression and, when combined with circESR1 ASO and CDK4/6 inhibitors, helps overcome antiestrogen resistance in breast cancer xenograft models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354955,1790890172,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(3): 1520-1541. doi: 10.7150/ijbs.126014  \nResearch Paper  \nThe Interaction of CircESR1 and HNRNPAB Regulates Cell Cycle Transition of Breast Cancer Cell  \nJunchao Xu1,2,3,4, Qiao Xu5, Tingfang Cao1,2,3, Miaomiao Wang1,2,3, Yinzhong Shang1,2,3,4, Junyan Tang1,2,3, Sheng Wu1, Xiaopeng Ma5, Xinghua Han1, Peter E. Lobie4,6􀀍, Liting Qian7􀀍, Tao Zhu1,2,3,4􀀍  \n1. Department of Oncology, The First Affiliated Hospital of USTC, State Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, China.  \n2. Institute of Cancer Research, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, China.  \n3. Anhui Key Laboratory of Molecular Oncology, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China.  \n4. Shenzhen Bay Laboratory, Shenzhen, Guangdong 518055, China.  \n5. Department of thyroid and breast Surgery, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, China.  \n6. Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong 518055, China.  \n7. Department of Radiation Oncology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, China.  \n􀀍 Corresponding authors: Tao Zhu, MD, Ph.D., Hefei National Laboratory and Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China. E-mail: [zhut@ustc.edu.cn. Or Liting Qian](zhut@ustc.edu.cn. Or Liting Qian), MD, Ph.D., Department of Radiation Oncology, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, China. E-mail: [money2004@sina.com. Or Peter E. Lobie](money2004@sina.com. Or Peter E. Lobie), MD, Ph.D., Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong 518055, [China. E-mail: pelobie@sz.tsinghua.edu.cn](China. E-mail: pelobie@sz.tsinghua.edu.cn).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.09.28; Accepted: 2025.12.03; Published: 2026.01.14  \nAbstract  \nThe mechanisms by which circRNAs regulate estrogen receptor (ER)-positive breast progression and therapeutic resistance remain poorly defined. By screening circRNAs involved in ER signaling, circESR1 was identified as a novel circRNA exhibiting high specificity of expression in ER+ breast cancer. CircESR1 interacted with HNRNPAB, which was transcriptionally activated by ER/SP1 signaling. HNRNPAB promoted the back-splicing and expression of circESR1 by binding to the Alu elements of cognate pre-mRNA; and circESR1 transcripts increased the stability and expression of HNRNPAB, ensuring an efficient positive feedback loop as reflected in antiestrogen-resistant breast cancer cells. Furthermore, HNRNPAB interacted and stabilized CDK1 and CDK6 mRNA, which was facilitated by its asymmetrical binding of circESR1, to promote cell cycle progression. Patients whose cancer exhibited high levels of circESR1 and/or HNRNPAB exhibited ad","cbCaiklSyretAqSR","https://ap.wps.com/l/cbCaiklSyretAqSR","pdf",10890673,22,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What circRNA is identified as a key regulator in ER+ breast cancer signaling?\",\"answer\":\"circESR1 is identified as a novel circRNA with high expression specificity in ER+ breast cancer, acting within an ER/SP1–driven regulatory context.\"},{\"question\":\"How does circESR1 interact with HNRNPAB and what is the consequence?\",\"answer\":\"circESR1 interacts with HNRNPAB, which is transcriptionally activated by ER/SP1 signaling. HNRNPAB promotes circESR1 back-splicing and expression, and circESR1 transcripts enhance HNRNPAB stability and expression, forming a positive feedback loop.\"},{\"question\":\"Which molecules are stabilized by HNRNPAB to promote cell cycle progression and therapy response?\",\"answer\":\"HNRNPAB interacts with and stabilizes CDK1 and CDK6 mRNA. This supports cell cycle progression and, when combined with circESR1 ASO and CDK4/6 inhibitors, helps overcome antiestrogen resistance in breast cancer xenograft models.\"}]","The Interaction of CircESR1 and HNRNPAB Regulates Cell Cycle Transition of Breast Cancer Cell | PDF",1790115039,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd77905ab0597d4d4a2de7673ed84b9a.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b886af268029c7b7092f5c7e47968c6b.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34de160f7fac537fc06c04c54109cfb5.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c50142ba975aa5198be4123214f4fc6.webp",980,1268]